domingo, 28 de marzo de 2021

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study - The Lancet Rheumatology

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario